Cardiac metabolism and mechanics are altered by genetic loss of lipoprotein triglyceride lipolysis

Cardiovascular Drugs and Therapy

Volumn 20, Issue 6, 2006, Pages 441-444

  Noh, Hye Lim ^a   Yamashita, Haruyo ^a   Goldberg, Ira J ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Cardiac metabolism; Cardiomyocyte; Lipid secretion

Indexed keywords

ALBUMIN; FATTY ACID; GLUCOSE; LIPID; LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARDIOTOXICITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXPERIMENTAL MOUSE; FATTY ACID OXIDATION; GENE DELETION; GENE LOSS; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; HEART; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; LIPOGENESIS; LIPOLYSIS; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARDIOMYOPATHY, DILATED; ENERGY METABOLISM; FATTY ACIDS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPOLYSIS; LIPOPROTEINS; METABOLIC NETWORKS AND PATHWAYS; MYOCARDIUM; MYOCYTES, CARDIAC; TRIGLYCERIDES;

EID: 33846421577     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-006-0633-1     Document Type: Review

References (12)

1. Ballard FB, Danforth WH, Naegle S, Bing RJ. Myocardial metabolism of fatty acids. J Clin Invest 1960;39:717-23.
2. Srinivasan M, Herrero P, McGill JB, Bennik J, Heere B, Lesniak D, et al. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2005;46:42-8.
3. Pillutla P, Hwang YC, Augustus A, Yokoyama M, Yagyu H, Johnston TP et al. Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy. Am J Physiol Endocrinol Metab 2005;288:E1229-35.
4. Augustus A, Yagyu H, Haemmerle G, Bensadoun A, Vikramadithyan RK, Park SY, et al. Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression. J Biol Chem 2004;279:25050-7.
5. Levak-Frank S, Hofmann W, Weinstock PH, Radner H, Sattler W, Breslow JL, et al. Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels. Proc Natl Acad Sci USA 1999;96:3165-70.
6. Herrero P, Peterson LR, McGill JB, Matthew S, Lesniak D, Dence C, et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2006;47:598-604.
7. Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, et al. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem 2006;281:8716-23.
8. Noh HL, Okajima K, Molkentin JD, Homma S, Goldberg IJ. Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction. Am J Physiol Endocrinol Metab 2006;291:E755-60.
9. Petrich BG, Molkentin JD, Wang Y. Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination. Faseb J 2003;17:749-51.
10. Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 2003;111:419-26.
11. Yokoyama M, Yagyu H, Hu Y, Seo T, Hirata K, Homma S, et al. Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse. J Biol Chem 2004;279:4204-11.
12. Vikramadithyan RK, Hirata K, Yagyu H, Hu, Y, Augustus A, Homma S, et al. Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy. J Pharmacol Exp Ther 2005;313:586-93.